| Literature DB >> 35867801 |
Rui Yang1,2, Danielle T Avery3, Katherine J L Jackson3, Masato Ogishi1, Ibtihal Benhsaien4,5, Likun Du6, Xiaofei Ye6, Jing Han1, Jérémie Rosain7,8, Jessica N Peel1, Marie-Alexandra Alyanakian9, Bénédicte Neven10, Sarah Winter8,11, Anne Puel1,7,8, Bertrand Boisson1,7,8, Kathryn J Payne3, Melanie Wong12,13, Amanda J Russell3, Yoko Mizoguchi14, Satoshi Okada14, Gulbu Uzel15, Christopher C Goodnow3,16, Sylvain Latour8,11, Jalila El Bakkouri4,5, Aziz Bousfiha4,5, Kahn Preece17, Paul E Gray18,19, Baerbel Keller20,21, Klaus Warnatz20,21, Stéphanie Boisson-Dupuis1,7,8, Laurent Abel1,7,8, Qiang Pan-Hammarström6, Jacinta Bustamante1,7,8,22, Cindy S Ma3,16, Jean-Laurent Casanova1,7,8,23,24, Stuart G Tangye3,16.
Abstract
High-level expression of the transcription factor T-bet characterizes a phenotypically distinct murine B cell population known as "age-associated B cells" (ABCs). T-bet-deficient mice have reduced ABCs and impaired humoral immunity. We describe a patient with inherited T-bet deficiency and largely normal humoral immunity including intact somatic hypermutation, affinity maturation and memory B cell formation in vivo, and B cell differentiation into Ig-producing plasmablasts in vitro. Nevertheless, the patient exhibited skewed class switching to IgG1, IgG4, and IgE, along with reduced IgG2, both in vivo and in vitro. Moreover, T-bet was required for the in vivo and in vitro development of a distinct subset of human B cells characterized by reduced expression of CD21 and the concomitantly high expression of CD19, CD20, CD11c, FCRL5, and T-bet, a phenotype that shares many features with murine ABCs. Mechanistically, human T-bet governed CD21loCD11chi B cell differentiation by controlling the chromatin accessibility of lineage-defining genes in these cells: FAS, IL21R, SEC61B, DUSP4, DAPP1, SOX5, CD79B, and CXCR4. Thus, human T-bet is largely redundant for long-lived protective humoral immunity but is essential for the development of a distinct subset of human CD11chiCD21lo B cells.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35867801 PMCID: PMC9413977 DOI: 10.1126/sciimmunol.abq3277
Source DB: PubMed Journal: Sci Immunol ISSN: 2470-9468